首页> 外文OA文献 >CLINICAL STUDY ON CEFMETAZOLE SODIUM FOR TREATING AND PREVENTING URINARY TRACT INFECTION
【2h】

CLINICAL STUDY ON CEFMETAZOLE SODIUM FOR TREATING AND PREVENTING URINARY TRACT INFECTION

机译:头孢他唑钠治疗和预防尿路感染的临床研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The in vitro antibacterial activity of cefmetazole sodium on four kinds of clinically isolated bacterial species was determined, and the clinical effect of the drug in 20 cases of postoperative or chroniccomplicated urinary tract infection was studied. l) The maximum sensitivity distribution rate was under 1.56 µg/ml of MIC either on 10[6]cells/ml or 10[8]cells/ml of inoculum size in 25 strains of E. coli, 25 strains of Klebsiella pneumoniae, 25 strains of Genus proteus and 20 strains of Staphylococcus aureus. This indicates that the antibacterial activity of cefmetazole sodium was little influenced by the inoculum size of any of the bacterial species. 2) The patients were 13 males and 7 females with a mean age of 56.7 years. The cause of urinary tract infection was urological tumors in 6 cases, urolithiasis in 4 cases, neurogenic bladder in 3 cases, trauma in 2 cases, inflammation in 2 cases and others in 3 cases. Various operations were performed on 15 patients, and the other 5 patients were not operated on. Catheters were inserted into the urethra or renal pelvis, or ureterocutaneostomy was done in 13 cases; 7 patients did not have catheters inserted. 3) Two to 4 g of cefmetazo1e sodium per day was administered intravenously. The mean duration of chemotherapy was 9.3 days and mean total dose of administration was 25.5 g. 4) The clinical effect of the drug was judged good, unchanged or poor chiefly based on the change of urinalyses. Depending on these criteria, 4 cases which were determined unchanged, were finally judged good as all of them had had catheters inserted. Overall results were good in 12 cases and poor in 8 cases. Effective rate, therefore, was 60%. 5) Comparison of the effectiveness of the drug for the patients who had had catheters inserted to those who had not, showed that the administration of cefmetazo1e sodium was also effective in treating chronic urinary tract infection even when catheters were used. A good effect was seen in 6 of the 7 cases (86%) in which catheters were not used, and in 6 of the 13 cases (46%) in which catheters were used.
机译:确定了头孢美唑钠对四种临床分离出的细菌的体外抗菌活性,并研究了该药物在20例术后或慢性复杂性尿路感染中的临床效果。 l)在25株大肠杆菌,25株肺炎克雷伯菌,25株大肠杆菌,10 [6]细胞/ ml或10 [8]细胞/ ml接种量上,MIC的最大灵敏度分布率低于1.56 µg / ml MIC变形杆菌属菌株和金黄色葡萄球菌20株。这表明头孢美唑钠的抗菌活性几乎不受任何细菌种类接种量的影响。 2)患者为男13例,女7例,平均年龄56.7岁。尿路感染的原因是泌尿系肿瘤6例,尿路结石4例,神经源性膀胱3例,外伤2例,炎症2例,其他3例。 15例患者进行了各种手术,其余5例患者未进行手术。将导尿管插入尿道或肾盂,或行输尿管皮肤吻合术13例; 7例患者未插入导管。 3)每天静脉注射2至4克头孢甲唑钠。平均化疗时间为9.3天,平均总给药量为25.5 g。 4)主要根据尿液分析的变化判断该药物的临床效果好,不变或差。根据这些标准,确定4例未改变的病例,由于全部插入了导管,最终被判定为良好。总体结果好12例,差8例。因此,有效率为60%。 5)比较药物对已插入导管的患者和未插入导管的患者的有效性,结果表明,即使使用导管,头孢甲唑钠也可有效治疗慢性尿路感染。在未使用导管的7例中有6例(86%)看到了良好的效果,在13例未使用导管的6例中(46%)看到了良好的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号